Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, July 2000, p. 1930-1935, Vol. 44, No. 7
Laboratoire de Bactériologie,
Faculté de Médecine, 63001 Clermont-Ferrand
Cedex,1 and UMR 175, CNRS-MNHN,
29000 Quimper,2 France
Received 27 September 1999/Returned for modification 22 February
2000/Accepted 12 April 2000
0066-4804/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.
Prevalence of
-Lactamases among 1,072 Clinical
Strains of Proteus mirabilis: a 2-Year Survey in a
French Hospital
-Lactam resistance was studied in 1,072 consecutive P. mirabilis clinical strains isolated at the Clermont-Ferrand
teaching hospital between April 1996 and March 1998. The frequency of
amoxicillin resistance was 48.5%. Among the 520 amoxicillin-resistant
isolates, three resistance phenotypes were detected: penicillinase (407 strains [78.3%]), extended-spectrum
-lactamase (74 strains
[14.2%]), and inhibitor resistance (39 strains [7.5%]). The
penicillinase phenotype isolates were divided into three groups
according to the level of resistance to
-lactams, which was shown to
be related to the strength of the promoter. The characterization of the
different
-lactamases showed that amoxicillin resistance in P. mirabilis was almost always (97%) associated with TEM or
TEM-derived
-lactamases, most of which evolved via TEM-2.
*
Corresponding author. Mailing address: Laboratoire de
Bactériologie, Faculté de Médecine, 28, Place Henri
Dunant, 63001 Clermont-Ferrand Cedex, France. Phone: 33 (0)4 73 60 80 18. Fax: 33 (0)4 73 27 74 94. E. mail:
Catherine.CHANAL{at}u-clermont1.fr.
| Clin. Vaccine Immunol. | Clin. Microbiol. Rev. |
|---|---|
| J. Clin. Microbiol. | ALL ASM JOURNALS |